Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Article in English | IMSEAR | ID: sea-84968

ABSTRACT

AIMS OF THE STUDY: To study the prevalence of gallbladder disorders in type 2 diabetic patients and their correlation with patient factors like age, sex, weight, duration of diabetes and autonomic neuropathy. METHODOLOGY: Fifty type 2 diabetic patients and 30 healthy controls underwent realtime ultrasonography to study the prevalence of gallbladder disorders. The fasting gallbladder volume and contraction 60 minutes after a fatty meal of the diabetic subjects were compared with 30 age and sex matched healthy volunteers. The age, sex, weight, duration of diabetes, autonomic neuropathy, control of diabetes were correlated to the prevalence of gallbladder disorders in diabetic patients. RESULTS: 32% of the diabetic patients had ultrasonographic evidence of gallstones, as compared to 6.7% in healthy subjects. 73.7% of the diabetic patients with gallbladder disorders were females. Mean fasting gallbladder volume was significantly increased in diabetic patients (26.2 cm3) as compared to non-diabetic healthy subjects (15.8 cm3). Further mean fasting gallbladder volume of diabetic patients with gallbladder disorder (28.1 cm3) was found to be significantly larger than that of those patients without gallbladder disorder (24.6 cm3). Mean percentage of contractions of gallbladder 60 min after fatty meal was reduced in diabetic patients (53.1%) and it was observed to be further reduced in the patients with gallbladder disorder (41.8%). Mean fasting gallbladder volume was larger in diabetic subjects with autonomic neuropathy, than those without. However, difference in mean percentage contraction of gallbladder 60 min after fatty meal was not statistically significant. Mean duration of diabetes was significantly longer in diabetic patients with gallbladder disorder. CONCLUSIONS: We conclude that type 2 diabetic patients have increased prevalence of gallbladder disorder which can only partially be explained by autonomic neuropathy leading, to increased fasting volume. Factors like decreased cholecystokinin or decreased sensitivity of the smooth muscle of gallbladder to normal level of cholecystokinin need to be studied.


Subject(s)
Diabetes Mellitus, Type 1/complications , Dietary Fats/administration & dosage , Female , Gallbladder/drug effects , Gallbladder Diseases/complications , Humans , Male , Middle Aged , Risk Factors
2.
Medicina (B.Aires) ; 60(5/1): 580-6, 2000. graf
Article in Spanish | LILACS | ID: lil-275468

ABSTRACT

El clonixinato de lisina (CL) es un antiinflamatorio no esteroide (AINE) con pocos efectos adversos, por lo que se ha postulado que a concentraciones equivalentes a las encontradas en plasma humano después de dosis terapéuticas inhibiría en escaso grado la cicloxigenasa I (COX-I). Se efectuaron 3 experimentos. Experimento 1: se estudió el efecto in vitro de CL en concentraciones de 4 y 6 ug/ml, las que se corresponden con las alcanzadas en plasma con una dosis oral de 125 mg. Los segmentos de vesícula biliar (n = 6) se incubaron con 0.25 uCi de ácido araquidónico 14C y se midió la producción de prostaglandina E 2, prostaglandina F 2a y prostaglandina 6 ceto F 1a. El CL no modificó la producción basal de ninguna de las tres prostaglandinas, pero con 6 ug/ml disminuyó significativamente la producción de ácido 5- hidroxieicosatetraenico (5-HETE). Experimento 2: se administró una infusión continua de CL a 6 pacientes en el pre operatorio inmediato para lograr una concentración en estado estacioanrio entre 4 y 6 ug/ml. Se incubaron segmentos de vesícula biliar de estos 6 pacientes y de 6 pacientes control no tratados con ácido araquidónico 14 C. Se observó que los segmentos de vesícula biliar tratados con CL no mostraron inhibición de la producción de ninguna de las tres PGs, mientras que el 5-HETE liberado al medio fue significativamente menor. Experimento 3: 18 pacientes recibieron bolos EV de: CL 100mg (n1, = 6); CL 200 mg (n2, = 6) o indometacina (INDO) 50 mg (n3 = 6). Con ninguna de las dos dosis de CL se obtuvo inhibición de la síntesis de PGs, por el contrario de INDO inhibió su síntesis. Cuando se valoró la producción de 5-HETE, los dos AINES estudiados de se comportaron en forma distinta. El tratamiento con INDO no modificó el 5-F-HETE producido, mientras que el tratamiento con CL lo inhibió significativamente. En los tres tipos de estudios realizados in vitro e in vivo: infusión continua y bolo IV, el CL no inhibió la síntesis de PGs y disminuyó significativamente el 5-HETE.


Subject(s)
Humans , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Gallbladder/drug effects , Hydroxyeicosatetraenoic Acids/biosynthesis , Lysine/analogs & derivatives , Lysine/pharmacology , Prostaglandins/biosynthesis , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Blotting, Western , Gallbladder/enzymology , Indomethacin/pharmacology , Lysine/metabolism
3.
Acta physiol. pharmacol. ther. latinoam ; 49(3): 161-9, 1999. tab, graf
Article in English | LILACS | ID: lil-246055

ABSTRACT

Propinox is an antispasmodic drug frequently used in the treatment of disorders of the gastrointestinal tract, the uterus and the galbladder, but little is known about its relaxing activity in gallbladder tissue. The main objective of this study was to determine the antispasmodic activity of propinox, compared to other antispasmodics, in the gallblader and to assess its binding affinity to receptor sites which may be involved in its mechanism of action. Antispasmodic activity of propinox, (-) scopolamine-n-butyl bromide, atropine and verapamil was determined in human gallbladders to reduce the risk of interspecies variability. Inhibitory activities (ED50) of carbachol-induced contraction were: atropine 5.03x10(-8) M>propinox 1.25x10(-7) M> verapamil 6.63x10(-6)M> (-) scopolamine-n-butyl1 bromide 5.4x10(-5) M. pD'2 for propinox was 6.94, indicating non competitive inhibition of carbachol action. Radioligand binding studies were performed to determine if the antisplasmodic action of the drug involved binding to muscarinic receptors or calciumatagonist sites. The inhibition constant (Ki) of proponix for muscarinic receptors of guinea pig ileum smoth muscle, which contains a mixed M2-M3 receptor population, was 1.6x10(-6) M. Ki for brain muscarinic receptors (M1) was 1.0x10(-4) M, for cardiac receptors (M1) was 1.0x10(-4)M, for receptors (M2) 1.2x10(-6)M and from salivary gland receptors (M3) 1.5x10(-6)M. For binding to the dihidropiridine calcium antagonist binding sites, Ki were: 4.9x10(-5)M for propinox and 2.2x10(-7)M for verapamil. For the phenylakylamine binding sites Ki were: 5.0x10(-6)M for propinox and 3.5x10(-8)M for verapamil. For the benzothiacepine binding sites, Ki for propinox was 5.2x10(-6)M. The following may be concluded: 1- The antispasmodic activity of propinox in isolated human galbladder was was comparatively less potent than of atropine and more potent than those verapamil and (-) scopolamine-n-butyl bromide. 2- Propinox showed binding to muscarinic and calcium receptors that can be related to its antisplasmodic activity; suggesting that the drug is an antispasmodic with anticholinergic and musculotropic activity. 3.- The dual mechanism of action, anticholinergic and calcium-blocking, would induce synergism of pharmacodynamic effects and minimize adverse events of pure antimuscarinic drugs or calcium antagonists.


Subject(s)
Humans , Gallbladder/drug effects , Parasympatholytics/pharmacology , Receptors, Muscarinic , Atropine/pharmacology , Binding Sites , Butylscopolammonium Bromide/pharmacology , Calcium Channel Blockers/pharmacology , Carbachol/pharmacology , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Verapamil/pharmacology
5.
Acta cient. venez ; 41(4): 218-26, 1990. ilus, tab
Article in Spanish | LILACS | ID: lil-113283

ABSTRACT

Hay controversias sobre si el agua atraviesa la vía paracelular en epitelios de baja resistencia (por ejemplo, vesícula biliar). El objetivo de este trabajo es por tanto, estudiar una posible correlación entre el flujo de absorción de volumen (Jv) y la penetración del ión La3+ usando fluidos de diferentes osmolalidades, lo cual permite variar Jv. Vesículas biliares de cobayo se perfundieron in vitro a pH y temperatura fisiológicos con fluidos oxigenados a dos osmolalidades: 300 mOsm/Kg (isosmótico) y 100 mOsm/Kg (hiposmótico) que contenían dos concentraciones de La3+1 y 10mM para cada osmolalidad y se prepararon para estudios de microscopía electrónica de transmisión. Después se procedió a evaluar el grado de pentración del La3+ cuantificando el número de uniones penetradas por el marcador y la longitud de su recorrido dentro del espacio intercelular (en *m), el trayecto se midió comenzando en el borde apical y en dirección latero-basal. Jv se duplica en la condición hiposmótica y en las micrografías se aprecia mayor grado de penetración del La3+ por las vías paracelulares en las vesículas con mayor flujo de volumen. Hay ausencia de precipitados de La3+ en el citoplasma, el cual está satisfactoriamente preservado, aun a 100 mOsm/Kg, lo que muestra que la integridad de la membrana plasmática se mantiene. Esto indica que la penetración del La3+ varía con Jv. Los resultados obtenidos constituyen una evidencia para afirmar que la penetración de La3+ varía con Jv y que una fracción de este último se cumple a través de las vías paracelulares


Subject(s)
Guinea Pigs , Male , Gallbladder/ultrastructure , Lanthanum/pharmacology , Water/metabolism , Absorption , Epithelium/physiology , Extracellular Space/physiology , Gallbladder/drug effects , Gallbladder/metabolism , Microscopy, Electron , Water/physiology
SELECTION OF CITATIONS
SEARCH DETAIL